Hiroki Kabata

5.7k total citations · 2 hit papers
62 papers, 2.7k citations indexed

About

Hiroki Kabata is a scholar working on Physiology, Immunology and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Hiroki Kabata has authored 62 papers receiving a total of 2.7k indexed citations (citations by other indexed papers that have themselves been cited), including 25 papers in Physiology, 25 papers in Immunology and 19 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Hiroki Kabata's work include Asthma and respiratory diseases (24 papers), IL-33, ST2, and ILC Pathways (23 papers) and Eosinophilic Esophagitis (16 papers). Hiroki Kabata is often cited by papers focused on Asthma and respiratory diseases (24 papers), IL-33, ST2, and ILC Pathways (23 papers) and Eosinophilic Esophagitis (16 papers). Hiroki Kabata collaborates with scholars based in Japan, United States and Germany. Hiroki Kabata's co-authors include Kazuyo Moro, Shigeo Koyasu, Koichi Fukunaga, Koichiro Asano, David Artis, Tomoko Betsuyaku, Katsunori Masaki, Jun Miyata, Yuri Furusawa and Hiroshi Ueki and has published in prestigious journals such as Nature, Journal of Clinical Investigation and Nature Communications.

In The Last Decade

Hiroki Kabata

59 papers receiving 2.7k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

The neuropeptide neuromedin U stimulates innate lymphoid cells and type 2 inflammation

2017 405 citations Hiroki Kabata et al. profile →
Effectiveness of Face Masks in Preventing Airborne Transmission of SARS-CoV-2

2020 263 citations Hiroshi Ueki, Yuri Furusawa et al. mSphere profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Hiroki Kabata Japan	18	1.5k	984	844	539	227	62	2.7k
Hideaki Morita Japan	33	1.8k 1.2×	1.5k 1.5×	1.2k 1.4×	397 0.7×	810 3.6×	167	4.6k
Yao‐Hsu Yang Taiwan	38	1.4k 0.9×	541 0.5×	809 1.0×	1.3k 2.3×	553 2.4×	230	4.8k
Yu‐Tsan Lin Taiwan	32	760 0.5×	634 0.6×	529 0.6×	779 1.4×	498 2.2×	118	3.5k
Hsin‐Hui Yu Taiwan	25	728 0.5×	244 0.2×	341 0.4×	328 0.6×	270 1.2×	72	2.0k
Jozélio Freire de Carvalho Brazil	35	1.0k 0.7×	424 0.4×	217 0.3×	521 1.0×	63 0.3×	275	4.3k
Benjamin T. Suratt United States	31	1.1k 0.7×	573 0.6×	775 0.9×	1.2k 2.2×	164 0.7×	68	3.4k
Murugappan Ramanathan United States	31	295 0.2×	492 0.5×	969 1.1×	812 1.5×	919 4.0×	130	2.9k
Mara De Amici Italy	25	440 0.3×	229 0.2×	601 0.7×	410 0.8×	478 2.1×	176	2.3k
Kevin C. Welch United States	29	267 0.2×	1.1k 1.1×	1.2k 1.4×	408 0.8×	988 4.4×	108	3.0k
Steven R. White United States	37	690 0.5×	317 0.3×	1.4k 1.6×	1.3k 2.5×	312 1.4×	112	3.5k

Countries citing papers authored by Hiroki Kabata

Since Specialization

Citations

This map shows the geographic impact of Hiroki Kabata's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hiroki Kabata with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hiroki Kabata more than expected).

Fields of papers citing papers by Hiroki Kabata

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Hiroki Kabata. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hiroki Kabata. The network helps show where Hiroki Kabata may publish in the future.

Co-authorship network of co-authors of Hiroki Kabata

This figure shows the co-authorship network connecting the top 25 collaborators of Hiroki Kabata. A scholar is included among the top collaborators of Hiroki Kabata based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Hiroki Kabata. Hiroki Kabata is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Tashiro, Hiroki, Hiroki Kabata, Koichi Fukunaga, et al.. (2025). Thymic stromal lymphopoietin promotes ozone-induced inflammation in the airway. American Journal of Respiratory Cell and Molecular Biology. 74(4). 497–517.

Masaki, Katsunori, Maho Suzukawa, Norihiro Harada, et al.. (2024). Effectiveness of benralizumab in the Tokyo Asthma Study (TOAST): A real-world prospective interventional trial. Allergology International. 74(2). 274–282. 3 indexed citations

Miyata, Jun, Yusuke Kawashima, Ryo Konno, et al.. (2024). Inflammatory profile of eosinophils in asthma-COPD overlap and eosinophilic COPD: a multi-omics study. Frontiers in Immunology. 15. 1445769–1445769. 5 indexed citations

Miyata, Jun, Yusuke Kawashima, Ryo Konno, et al.. (2024). Multiomics analysis identified IL-4–induced IL1RL1high eosinophils characterized by prominent cysteinyl leukotriene metabolism. Journal of Allergy and Clinical Immunology. 154(5). 1277–1288. 6 indexed citations

Sasaki, Hisashi, Jun Miyata, Yusuke Kawashima, et al.. (2024). Aspergillus fumigatus extract modulates human eosinophils via NOD2 and oxidative stress. Allergology International. 74(1). 156–165. 1 indexed citations

Chubachi, Shotaro, Junki Miyamoto, Takashi Shimada, et al.. (2024). Impact of smoking on gut microbiota and short-chain fatty acids in human and mice: Implications for COPD. Mucosal Immunology. 18(2). 353–365. 9 indexed citations

Yamagishi, Mai, Takashi Kamatani, Hiroki Kabata, et al.. (2024). Quantitative live-cell imaging of secretion activity reveals dynamic immune responses. iScience. 27(6). 109840–109840. 1 indexed citations

Kabata, Hiroki, et al.. (2024). Protocol for lentiviral vector-based gene transfection in human ILC2s. STAR Protocols. 5(1). 102854–102854. 1 indexed citations

Tanaka, Yumiko, Mai Yamagishi, Yasutaka Motomura, et al.. (2023). Time-dependent cell-state selection identifies transiently expressed genes regulating ILC2 activation. Communications Biology. 6(1). 915–915. 2 indexed citations

10.

Mikami, Yu, Hideo Shindou, Tomoyuki Suzuki, et al.. (2022). Lysophosphatidylcholine Acyltransferase 1 Deficiency Promotes Pulmonary Emphysema via Apoptosis of Alveolar Epithelial Cells. Inflammation. 45(4). 1765–1779. 13 indexed citations

11.

Baba, Rie, Hiroki Kabata, Yoshitaka Shirasaki, et al.. (2022). Upregulation of IL-4 receptor signaling pathway in circulating ILC2s from asthma patients. Journal of Allergy and Clinical Immunology Global. 1(4). 299–304. 10 indexed citations

12.

Kabata, Hiroki, et al.. (2022). Current summary of clinical studies on anti-TSLP antibody, Tezepelumab, in asthma. Allergology International. 72(1). 24–30. 23 indexed citations

13.

So, Matsuo, Hiroki Kabata, Mai Takahashi, Natalia Egorova, & Toshiki Kuno. (2021). The Association of Inhaled Corticosteroid Before Admission and Survival of Patients with COVID-19. Journal of Aerosol Medicine and Pulmonary Drug Delivery. 34(4). 265–267. 10 indexed citations

14.

Masaki, Katsunori, Jun Miyata, Takashi Kamatani, et al.. (2020). Risk factors for poor adherence to inhaled corticosteroid therapy in patients with moderate to severe asthma. Asian Pacific Journal of Allergy and Immunology. 41(2). 113–120. 5 indexed citations

15.

Ueki, Hiroshi, Yuri Furusawa, Kiyoko Iwatsuki‐Horimoto, et al.. (2020). Effectiveness of Face Masks in Preventing Airborne Transmission of SARS-CoV-2. mSphere. 5(5). 263 indexed citations breakdown →

16.

Kabata, Hiroki, Kazuyo Moro, & Shigeo Koyasu. (2018). The group 2 innate lymphoid cell ( ILC 2) regulatory network and its underlying mechanisms. Immunological Reviews. 286(1). 37–52. 215 indexed citations

17.

Kabata, Hiroki, Kazuyo Moro, Shigeo Koyasu, et al.. (2016). Mechanisms to Suppress ILC2-induced Airway Inflammation. Annals of the American Thoracic Society. 13(Supplement_1). S95–S95. 9 indexed citations

18.

Kabata, Hiroki, Kazuyo Moro, Shigeo Koyasu, & Koichiro Asano. (2015). Group 2 innate lymphoid cells and asthma. Allergology International. 64(3). 227–234. 63 indexed citations

19.

Fujinawa, Reiko, Congxiao Gao, Hiroki Kabata, et al.. (2014). ランゲリン/CD207のケラタン硫酸二糖,Gal(6SO 3 )β1,4-GlcNAc(6SO 3 )とそのトライアングル誘導体へのin vitroおよびin vivoでの結合:COPD(慢性閉塞性肺疾患)の創薬標的候補. Glycobiology. 24(11). 1218. 2 indexed citations

20.

Fujinawa, Reiko, Congxiao Gao, Hiroki Kabata, et al.. (2014). Binding of langerin/CD207 to keratan sulfate disaccharide, Gal (6SO3) β1, 4-GlcNAc (6SO3) and its triangle derivative in vitro and in vivo: possible drug targets for COPD (chronic obstructive pulmonary disease). Max Planck Digital Library. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact